Zacks Research Upgrades Itron (NASDAQ:ITRI) to Hold

Itron (NASDAQ:ITRIGet Free Report) was upgraded by research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued on Wednesday,Zacks.com reports.

A number of other research analysts have also recently issued reports on the stock. Roth Capital reiterated a “buy” rating and set a $136.00 price objective on shares of Itron in a report on Wednesday, April 29th. Weiss Ratings restated a “hold (c)” rating on shares of Itron in a report on Friday, May 8th. Raymond James Financial began coverage on shares of Itron in a research report on Tuesday, April 21st. They issued an “underperform” rating on the stock. Needham & Company LLC boosted their price objective on Itron from $116.00 to $128.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, JPMorgan Chase & Co. lowered their price objective on Itron from $133.00 to $113.00 and set an “overweight” rating for the company in a research note on Thursday, April 16th. Eight equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $131.33.

Read Our Latest Report on ITRI

Itron Trading Down 3.4%

ITRI opened at $98.85 on Wednesday. The company has a market cap of $4.33 billion, a P/E ratio of 16.50, a price-to-earnings-growth ratio of 0.84 and a beta of 1.32. The company has a fifty day moving average price of $84.38 and a two-hundred day moving average price of $89.82. The company has a current ratio of 2.75, a quick ratio of 2.24 and a debt-to-equity ratio of 0.96. Itron has a 1-year low of $77.77 and a 1-year high of $142.00.

Itron (NASDAQ:ITRIGet Free Report) last released its quarterly earnings data on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.29 by $0.30. The firm had revenue of $562.90 million during the quarter, compared to the consensus estimate of $566.34 million. Itron had a return on equity of 19.26% and a net margin of 11.90%.The company’s quarterly revenue was down 7.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.62 earnings per share. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. Analysts predict that Itron will post 6.45 EPS for the current fiscal year.

Insider Activity at Itron

In other news, SVP Donald L. Reeves III sold 319 shares of the business’s stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total value of $26,914.03. Following the transaction, the senior vice president owned 29,100 shares in the company, valued at $2,455,167. The trade was a 1.08% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP John F. Marcolini sold 322 shares of the stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total value of $27,167.14. Following the sale, the senior vice president directly owned 24,689 shares of the company’s stock, valued at $2,083,010.93. The trade was a 1.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 3,946 shares of company stock valued at $324,420 over the last ninety days. Corporate insiders own 1.77% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Private Trust Co. NA lifted its stake in Itron by 112.4% in the fourth quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock valued at $25,000 after purchasing an additional 145 shares during the last quarter. Employees Retirement System of Texas bought a new position in shares of Itron in the third quarter worth $32,000. Northwestern Mutual Wealth Management Co. raised its position in shares of Itron by 29.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock worth $41,000 after buying an additional 101 shares in the last quarter. Advisory Services Network LLC purchased a new stake in shares of Itron in the third quarter worth $49,000. Finally, EverSource Wealth Advisors LLC boosted its stake in Itron by 25.3% during the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock valued at $53,000 after buying an additional 81 shares during the period. Hedge funds and other institutional investors own 96.19% of the company’s stock.

More Itron News

Here are the key news stories impacting Itron this week:

  • Positive Sentiment: Itron reported second-quarter adjusted earnings of $1.59 per share, well above the $1.29 analyst consensus. Strong margins, demand for its services and a solid backlog helped offset revenue of $562.9 million, which fell short of expectations. ITRI Q2 Earnings Top Despite Soft Revenues, Solid View Lifts Stock 26%
  • Positive Sentiment: Management raised its fiscal 2026 earnings outlook to $6.30-$6.50 per share and projected third-quarter EPS of $1.50-$1.60. Investors viewed the improved profit outlook and margin performance as more important than the revenue shortfall, triggering a sharp post-earnings rally. Itron jumps after profit beat and upbeat outlook
  • Positive Sentiment: Needham raised its price target from $116 to $128 and maintained a Buy rating, implying substantial potential upside from recent trading levels. The average analyst target indicates approximately 25% upside, although price-target estimates are not always reliable. Itron Raises Profit Outlook While Revenue Growth Remains Uneven
  • Neutral Sentiment: Zacks highlighted Itron’s valuation, growth and momentum characteristics, while noting that analyst estimate revisions are a more useful signal than the consensus price target alone. Are Investors Undervaluing Itron Right Now?
  • Negative Sentiment: Revenue declined 7.2% year over year, and the quarterly sales miss plus an initially softer third-quarter sales outlook raise concerns about uneven top-line growth. The recent pullback also appears consistent with profit-taking after the stock’s large post-earnings advance. Itron Missed Revenue and Still Jumped 26%

About Itron

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

Recommended Stories

Analyst Recommendations for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.